Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 17-AAG | 0.1 | uM | 7 | 625.00 | 270.29 | 334.00 | 763.50 | 0.4375 | 0.1517 |
| BT-20 | Lapatinib | 0.01 | uM | 7 | 625.00 | 270.29 | 881.00 | 763.50 | 1.1539 | 1.2005 |
| BT-20 | 0 | uM | 7 | 625.00 | 270.29 | 640.00 | 763.50 | 0.8382 | 0.7778 | |
| BT-20 | 0 | uM | 7 | 625.00 | 270.29 | 4.00 | 763.50 | 0.0052 | -0.9399 | |
| BT-20 | 0 | uM | 7 | 1250.00 | 580.08 | 5.00 | 1791.00 | 0.0028 | -0.9462 | |
| BT-20 | 0 | uM | 7 | 1250.00 | 580.08 | 1782.00 | 1791.00 | 0.9950 | 0.9938 | |
| BT-20 | 0 | uM | 7 | 1250.00 | 580.08 | 1492.00 | 1791.00 | 0.8331 | 0.7875 | |
| BT-20 | 17-AAG | 3.1623 | uM | 7 | 1250.00 | 580.08 | 617.00 | 1791.00 | 0.3445 | 0.0387 |
| BT-20 | Lapatinib | 0.0033113 | uM | 7 | 1250.00 | 580.08 | 1631.00 | 1791.00 | 0.9107 | 0.8882 |
| BT-20 | Lapatinib | 0.031623 | uM | 7 | 1250.00 | 580.08 | 1891.00 | 1791.00 | 1.0558 | 1.0679 |
| BT-20 | 17-AAG | 0.0033113 | uM | 7 | 1250.00 | 580.08 | 1332.00 | 1791.00 | 0.7437 | 0.6671 |
| BT-20 | Linsitinib | 1 | uM | 7 | 1250.00 | 580.08 | 1969.00 | 1791.00 | 1.0994 | 1.1200 |
| BT-20 | Lapatinib | 0.0016596 | uM | 7 | 1250.00 | 580.08 | 1826.00 | 1791.00 | 1.0195 | 1.0239 |
| BT-20 | 0 | uM | 7 | 1250.00 | 580.08 | 1988.00 | 1791.00 | 1.1100 | 1.1325 | |
| BT-20 | Linsitinib | 0.0033113 | uM | 7 | 1250.00 | 580.08 | 1839.00 | 1791.00 | 1.0268 | 1.0328 |
| BT-20 | Linsitinib | 0.1 | uM | 7 | 1250.00 | 580.08 | 2133.00 | 1791.00 | 1.1910 | 1.2269 |
| BT-20 | Lapatinib | 0.31623 | uM | 7 | 1250.00 | 580.08 | 1932.00 | 1791.00 | 1.0787 | 1.0954 |
| BT-20 | Linsitinib | 0.031623 | uM | 7 | 1250.00 | 580.08 | 1939.00 | 1791.00 | 1.0826 | 1.1001 |
| BT-20 | 17-AAG | 10 | uM | 7 | 1250.00 | 580.08 | 553.00 | 1791.00 | 0.3088 | -0.0290 |
| BT-20 | Lapatinib | 0.1 | uM | 7 | 1250.00 | 580.08 | 1934.00 | 1791.00 | 1.0798 | 1.0967 |
| BT-20 | 17-AAG | 0.31623 | uM | 7 | 1250.00 | 580.08 | 584.00 | 1791.00 | 0.3261 | 0.0041 |
| BT-20 | Linsitinib | 10 | uM | 7 | 1250.00 | 580.08 | 1400.00 | 1791.00 | 0.7817 | 0.7189 |
| BT-20 | Linsitinib | 0.31623 | uM | 7 | 1250.00 | 580.08 | 1572.00 | 1791.00 | 0.8777 | 0.8459 |
| BT-20 | Erlotinib | 0.31623 | uM | 7 | 1250.00 | 580.08 | 1783.00 | 1791.00 | 0.9955 | 0.9945 |
| BT-20 | Erlotinib | 3.1623 | uM | 7 | 1250.00 | 580.08 | 1564.00 | 1791.00 | 0.8733 | 0.8401 |